Risks posed by proposed tariffs on India’s generic pharmaceutical exports to the US.
President Donald Trump has unveiled intentions to implement tariffs of 25% or more on imports of semiconductors and pharmaceuticals, a decision that could have profound repercussions for India’s pharmaceutical sector. […]
Continue Reading
